
ICD-10 code for leukocytosis (Elevated white blood cell count), unspecified, D72.829, is one of the most commonly used codes in this category, but it is also one of the most confusing. Often coders and providers may confuse this code for D72.819, Leukocytosis, unspecified, however these codes have separate definitions, documentation needs, and coding scenarios.
In this article, we will look at D72.829 exclusively - its definition, correct usage scenarios, the category it belongs to, and everything else you need to know about billing with this code.
ICD-10 code D72.829 is listed in Chapter 3, Diseases of the Blood and Blood-forming Organs, and Certain Disorders Involving the Immune Mechanism, as a member of category D72 Other Disorders of White Blood Cells.
The particular subcategory of Elevated white blood cell count, D72.82, has undergone significant changes since the year 2022 of ICD-10-CM due to an expansion in the number of codes so as to provide more specificity in relation to different levels of WBC counts. In particular, the non-specific residual code within the subcategory D72.82 is D72.829, which can only be assigned when a patient’s WBC count is noted to be elevated without any knowledge of the cause or the particular cell type causing the increase in numbers.
It is critically important to understand the distinction between D72.829 and D72.819. D72.819 is Leukocytosis, unspecified” – this means that the patient has a diagnosis of leukocytosis from the doctor, but there is no known cause for it. On the other hand, D72.829 can be termed “Elevated white blood cell count, unspecified.” This is a different term since it describes a condition of elevation in the WBC count, even before a diagnosis of leukocytosis has been made. D72.829 is more accurate when used early in diagnosis.
The table below provides a complete reference for the ICD-10 code for leukocytosis and its related subcodes, including the clinical contexts where each applies and key documentation requirements.
There are a few scenarios when D72.829 will be an incorrect code assignment, irrespective of what appears in the lab report:
For D72.829 to be applied, it must be substantiated by the clinical documentations. For the outpatient setting, according to ICD-10-CM guidelines, the codes have to be substantiated by the physician's documentation and not just a laboratory test value. The coder is not supposed to assign a code for D72.829 simply because there is the abnormal laboratory value in the chart.
Clinical documentation will include, but not limited to:
For inpatients, according to the ICD-10-CM rules, a coder is allowed to assign a code for a diagnosis which is being assessed and treated at the time of admission even if it is based on the results of a laboratory study influencing patient care. In this case, the use of D72.829 could be justified for reporting an increased level of WBC that is not related to another more precise diagnosis. Also, coders can request further information from a doctor concerning the presence of such an increase.
The most common mistake is using D72.829 as a default code in place of the other D72.82x codes for elevated WBCs that can be coded separately from D72.829. If a physician uses "neutrophilic leukocytosis" as the diagnosis or notes lymphocytosis on CBC with differential results, the use of D72.829 by default will be a problem since there are more specific codes available.
These two codes are often confused with each other. While D72.819 (Leukocytosis, unspecified) is a diagnosis established by a physician, D72.829 (Elevated white blood cell count, unspecified) is a laboratory finding which should be used if a diagnosis is yet to be established. D72.829 should not be used in case there is a physician's diagnosis of leukocytosis.
In cases where a leukemia or a myeloproliferative disorder is confirmed in the encounter, one should not use both codes as the latter has to be excluded in the same encounter. The Excludes1 note in category D72 makes the practice invalid.
Coders that look at lab test results and code for D72.829 based solely on a numerical finding without documentation from a physician indicating the finding is coding off source data rather than documented information. This is non-compliance in an outpatient environment.
The most commonly seen CPT codes for laboratory or evaluation purposes where D72.829 is the supporting diagnosis include:
RapidClaims is an automated tool in healthcare revenue cycle management which utilizes AI technology to ensure the clinical documentations are coded using the most specific and medically-defensible ICD-10 code available. This is because the coding system uses its coding engine to validate diagnosis codes against procedure codes, check for NCCI editing, apply payer LCDs, and highlight documentation deficiency prior to the filing of a claim to the clearinghouse. In cases of hematology practice, internal medicine, oncology, and emergency medicine in which the disease may present in many ways, this coding precision ensures that there is no revenue leakage due to wrong codes or generic ICD-10 codes.
D72.829 is a valid and helpful ICD-10 code for leukocytosis, but only when used appropriately. This code should be assigned for situations when there is an objective high white blood cell count, the provider recognizes the diagnosis, and there is no further documentation available to assign a code from the D72.82x series or a malignant neoplasm. In addition, D72.829 is not a universal solution; it is not synonymous with D72.819.
Understanding the difference between these diagnoses will make claims accurate and help in case of an audit, and will contribute to the quality of the medical data that goes into population health reporting and risk adjustment. Coding software such as RapidClaims was specifically designed to handle such coding tasks, interpreting medical documentation on a per-encounter basis and assigning codes based on that analysis.
Unspecified Leukocytosis is coded using D72.829 which refers to a situation where leukocytes have been elevated without any underlying cause being identified.
This code can be used when there is documentation of leukocytosis in patient medical records that fail to indicate whether infection, inflammation, or other diseases are present.
Yes, D72.829 is a valid ICD-10-CM code that is also billable.
In cases where the cause of Leukocytosis can be identified (like in the case of an infection), the coder should begin by identifying the root cause.
It can be used for this purpose when the patient presents with a problem primarily relating to their leukocytosis without any other underlying cause being identified.
.png)
Mary Degapogu is a proficient medical coder with 6 years of experience in E/M Outpatient and ED Profee coding, focused on precise code assignment and documentation compliance to drive clean claims and revenue integrity at RapidClaims.
